Browsing by Subject "A61K 31/437"
Now showing items 1-1 of 1
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2018-01-16)The disclosure provides rifamycin and rifamycin derivative compositions, including rifabutin and rifabutin derivative compositions able to cause drug-sensitization in a cancer cell or inhibition of a cancer cell. The ...